230 related articles for article (PubMed ID: 29610390)
21. Dedifferentiation within well-differentiated liposarcoma of the extremity or trunk: Implications for clinical management.
Tseng WW; Barretta F; Baia M; Barisella M; Radaelli S; Callegaro D; Yoon DH; Fiore M; Gronchi A
J Surg Oncol; 2021 Oct; 124(5):838-845. PubMed ID: 34254688
[TBL] [Abstract][Full Text] [Related]
22. Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma.
Jagosky MH; Anderson CJ; Symanowski JT; Steuerwald NM; Farhangfar CJ; Baldrige EA; Benbow JH; Livingston MB; Patt JC; Ahrens WA; Kneisl JS; Kim ES
Cancer Med; 2023 Mar; 12(6):7029-7038. PubMed ID: 36464833
[TBL] [Abstract][Full Text] [Related]
23. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
Nessim C; Raut CP; Callegaro D; Barretta F; Miceli R; Fairweather M; Blay JY; Strauss D; Rutkowski P; Ahuja N; Gonzalez R; Grignani G; Quagliuolo V; Stoeckle E; Lahat G; De Paoli A; Pillarisetty VG; Canter RJ; Mullen JT; Pennacchioli E; van Houdt W; Swallow CJ; Schrage Y; Cardona K; Fiore M; Gronchi A; Bagaria SP
Ann Surg Oncol; 2021 Nov; 28(12):7854-7863. PubMed ID: 33907921
[TBL] [Abstract][Full Text] [Related]
25. MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors.
Ware PL; Snow AN; Gvalani M; Pettenati MJ; Qasem SA
Am J Clin Pathol; 2014 Mar; 141(3):334-41. PubMed ID: 24515760
[TBL] [Abstract][Full Text] [Related]
26. Critical histopathological analysis of 25 dedifferentiated liposarcomas, including uncommon variants, reviewed at a Tertiary Cancer Referral Center.
Rekhi B; Navale P; Jambhekar NA
Indian J Pathol Microbiol; 2012; 55(3):294-302. PubMed ID: 23032820
[TBL] [Abstract][Full Text] [Related]
27. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability.
Crago AM; Socci ND; DeCarolis P; O'Connor R; Taylor BS; Qin LX; Antonescu CR; Singer S
Clin Cancer Res; 2012 Mar; 18(5):1334-40. PubMed ID: 22241790
[TBL] [Abstract][Full Text] [Related]
28. Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations.
Somaiah N; Beird HC; Barbo A; Song J; Mills Shaw KR; Wang WL; Eterovic K; Chen K; Lazar A; Conley AP; Ravi V; Hwu P; Futreal A; Simon G; Meric-Bernstam F; Hong D
Oncotarget; 2018 Apr; 9(28):19891-19899. PubMed ID: 29731991
[TBL] [Abstract][Full Text] [Related]
29. Computed tomography scan-driven selection of treatment for retroperitoneal liposarcoma histologic subtypes.
Lahat G; Madewell JE; Anaya DA; Qiao W; Tuvin D; Benjamin RS; Lev DC; Pollock RE
Cancer; 2009 Mar; 115(5):1081-90. PubMed ID: 19156920
[TBL] [Abstract][Full Text] [Related]
30. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
[TBL] [Abstract][Full Text] [Related]
31. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
[TBL] [Abstract][Full Text] [Related]
32. Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution.
Muratori F; Frenos F; Bettini L; Matera D; Mondanelli N; Scorianz M; Cuomo P; Scoccianti G; Beltrami G; Greto D; Livi L; Baldi G; Roselli G; Capanna R; Campanacci DA
J Orthop Sci; 2018 Nov; 23(6):1038-1044. PubMed ID: 30007495
[TBL] [Abstract][Full Text] [Related]
33. Well-differentiated liposarcoma (atypical lipomatous tumors).
Laurino L; Furlanetto A; Orvieto E; Dei Tos AP
Semin Diagn Pathol; 2001 Nov; 18(4):258-62. PubMed ID: 11757865
[TBL] [Abstract][Full Text] [Related]
34. Liposarcoma: new entities and evolving concepts.
Dei Tos AP
Ann Diagn Pathol; 2000 Aug; 4(4):252-66. PubMed ID: 10982304
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
[TBL] [Abstract][Full Text] [Related]
36. Second Primary Malignancies in Patients with Well-differentiated/Dedifferentiated Liposarcoma.
Jung E; Fiore M; Gronchi A; Grignol V; Pollock RE; Chong SS; Chopra S; Hamilton AS; Tseng WW
Anticancer Res; 2018 Jun; 38(6):3535-3542. PubMed ID: 29848707
[TBL] [Abstract][Full Text] [Related]
37. Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection.
Butò S; Pierotti MA; Tamborini E; Della Torre G; Lavarino C; Rilke F; Pilotti S
Diagn Mol Pathol; 1999 Sep; 8(3):125-30. PubMed ID: 10565683
[TBL] [Abstract][Full Text] [Related]
38. Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies.
Thway K; Jones RL; Noujaim J; Zaidi S; Miah AB; Fisher C
Adv Anat Pathol; 2016 Jan; 23(1):30-40. PubMed ID: 26645460
[TBL] [Abstract][Full Text] [Related]
39. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution.
Mussi C; Collini P; Miceli R; Barisella M; Mariani L; Fiore M; Casali PG; Gronchi A
Cancer; 2008 Oct; 113(7):1657-65. PubMed ID: 18704991
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma.
He M; Aisner S; Benevenia J; Patterson F; Harrison LE; Hameed M
Pathol Res Pract; 2009; 205(6):386-94. PubMed ID: 19186005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
